PsiThera
The role focuses on advancing peptide therapeutics, especially macrocyclic peptides and small molecule programs, from screening through to development candidate selection. It involves leading cross‑functional collaboration, implementing structure‑based and computational drug design, managing external synthesis teams, and ensuring data integrity throughout the discovery process.
PsiThera is advancing programs across multiple targets from the TNF superfamily and beyond, where no oral therapies currently exist.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for PsiThera.